Beta Bionics raises $204m to kickstart medtech IPO season
Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...
theacademic6 天
The chemistry behind continuous glucose sensing
Transforming global health demands smart chemistry, addressing urgent health challenges through innovative, durable medical ...